Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Liberty Live-C
LLYVK
5
American Express
AXP
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 8.51%149.87M | 9.44%38.19M | 14.61%37.28M | 14.85%38.28M | -3.28%36.14M | -12.75%138.12M | -6.53%34.89M | -27.94%32.53M | -16.38%33.33M | 3.87%37.37M |
Cost of revenue | 9.01%101.75M | 13.09%26.3M | 13.40%24.5M | 11.10%25.57M | -1.00%25.21M | -15.20%93.35M | -16.42%23.26M | -32.19%21.61M | -12.05%23.02M | 5.16%25.47M |
Gross profit | 7.46%48.11M | 2.15%11.88M | 17.01%12.78M | 23.22%12.71M | -8.15%10.93M | -7.17%44.77M | 22.44%11.63M | -17.73%10.92M | -24.66%10.32M | 1.22%11.9M |
Operating expense | -12.76%13.98M | -17.20%3.37M | -22.67%2.96M | 6.21%4.1M | -14.47%3.64M | 25.76%16.02M | 47.15%4.07M | 12.34%3.83M | 15.11%3.86M | 32.73%4.26M |
Selling and administrative expenses | -13.68%12.86M | -22.80%3.75M | -16.12%3.41M | -0.55%4.31M | -12.00%3.9M | 31.27%14.9M | 7,434.50%4.86M | 7.84%4.07M | 17.03%4.34M | 16.44%4.43M |
-Selling and marketing expense | 2.24%2.59M | -9.52%618K | 17.13%711K | 4.55%597K | 0.30%674K | -9.69%2.53M | -11.41%683K | 3.41%607K | -23.46%571K | -4.14%672K |
-General and administrative expense | -16.94%10.27M | -24.98%3.13M | -21.95%2.7M | -1.33%3.72M | -14.19%3.23M | 44.71%12.37M | 691.09%4.18M | 8.66%3.46M | 27.23%3.77M | 21.08%3.76M |
Depreciation and amortization | -11.84%2.47M | ---- | ---- | ---- | ---- | -26.22%2.8M | ---- | ---- | ---- | ---- |
-Depreciation | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Amortization | -11.84%2.47M | ---- | ---- | ---- | ---- | -26.22%2.8M | ---- | ---- | ---- | ---- |
Other operating expenses | 39.23%-50.93K | ---- | ---- | ---- | ---- | ---83.8K | ---84K | ---- | ---- | ---- |
Total other operating income | -18.35%1.3M | -45.77%385K | 89.87%450K | -55.70%210K | 47.73%260K | -33.63%1.6M | -35.08%710K | -34.53%237K | 35.43%474K | -70.67%176K |
Operating profit | 18.72%34.14M | 12.54%8.52M | 38.46%9.82M | 33.41%8.61M | -4.63%7.29M | -18.98%28.75M | 12.31%7.57M | -28.13%7.09M | -37.57%6.45M | -10.61%7.64M |
Net non-operating interest income (expenses) | -13.31%990.93K | -22.96%245K | -26.54%321K | 12.39%263K | 5.19%162K | 105.85%1.14M | 38.08%318K | 154.07%437K | 114.68%234K | 250.00%154K |
Non-operating interest income | -13.31%990.93K | -22.96%245K | -26.54%321K | 12.39%263K | 5.19%162K | 105.85%1.14M | 38.08%318K | 154.07%437K | 114.68%234K | 250.00%154K |
Non-operating interest expense | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Net investment income | -154.55%-1M | 210.20%1.06M | -529.20%-3.22M | -54.80%358K | 1,650.00%775K | -51.98%1.84M | 1,699.58%343K | -60.28%750K | -41.16%792K | -108.79%-50K |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 18.33%6.44M | 112.52%2.44M | -40.71%683K | -20.29%1.54M | 46.53%1.77M | 110.38%5.44M | 268.84%1.15M | 4.82%1.15M | 206.18%1.93M | 121.61%1.21M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 207.28%41.55K | 148.89%44K | 0 | 0 | -12.50%49K | -117.37%-38.73K | -168.72%-90K | -102.78%-3K | 93.33%-1K | 5,700.00%56K |
Less:Impairment of capital assets | -57.76%1.79K | --0 | --0 | --0 | ---50K | -84.77%4.25K | 367.62%3K | --0 | -96.43%1K | --0 |
Less:Other special charges | 51.67%-43.34K | -18.92%-44K | ---- | ---- | 101.79%1K | -550.05%-89.68K | -3,170.54%-37K | 250.00%3K | ---- | ---56K |
Less:Write off | --0 | --0 | ---- | ---- | ---- | 152.37%124.16K | 194.62%124K | ---- | ---- | ---- |
Other non-operating income (expenses) | 8.42%92.1K | -89.71%7K | 40.00%7K | 16.67%7K | 16.67%7K | 3.57%84.95K | 38.71%68K | -16.67%5K | 6K | -77.78%6K |
Income before tax | 9.35%40.7M | 31.67%12.32M | -19.32%7.61M | 14.45%10.78M | 11.49%10.05M | -12.95%37.22M | 25.10%9.36M | -28.22%9.43M | -24.11%9.42M | -7.36%9.02M |
Income tax | 17.57%9.61M | 45.81%2.96M | 3.65%2.1M | 11.95%2.37M | 0.25%2M | -17.14%8.17M | 36.02%2.03M | -33.14%2.03M | -29.60%2.12M | -14.26%2M |
Net income | 7.03%31.09M | 27.76%9.36M | -25.61%5.51M | 15.18%8.41M | 14.69%8.05M | -11.70%29.05M | 22.37%7.33M | -26.74%7.4M | -22.36%7.3M | -5.19%7.02M |
Net income continuous operations | 7.03%31.09M | 27.76%9.36M | -25.61%5.51M | 15.18%8.41M | 14.69%8.05M | -11.70%29.05M | 22.37%7.33M | -26.74%7.4M | -22.36%7.3M | -5.19%7.02M |
Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to the company | 7.03%31.09M | 27.76%9.36M | -25.61%5.51M | 15.18%8.41M | 14.69%8.05M | -11.70%29.05M | 22.37%7.33M | -26.74%7.4M | -22.36%7.3M | -5.19%7.02M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 7.03%31.09M | 27.76%9.36M | -25.61%5.51M | 15.18%8.41M | 14.69%8.05M | -11.70%29.05M | 22.37%7.33M | -26.74%7.4M | -22.36%7.3M | -5.19%7.02M |
Gross dividend payment | ||||||||||
Basic earnings per share | -0.80%0.0371 | 19.15%0.0112 | -30.53%0.0066 | 7.45%0.0101 | 7.61%0.0099 | -13.43%0.0374 | 18.99%0.0094 | -28.57%0.0095 | -23.58%0.0094 | -5.15%0.0092 |
Diluted earnings per share | 4.51%0.0371 | 19.15%0.0112 | -30.53%0.0066 | 11.24%0.0099 | 11.63%0.0096 | -12.13%0.0355 | 28.77%0.0094 | -23.39%0.0095 | -23.28%0.0089 | -6.52%0.0086 |
Dividend per share | 25.00%0.025 | 100.00%0.01 | 0 | 0.00%0.015 | 0 | 0.00%0.02 | 0.00%0.005 | 0 | 0.00%0.015 | 0 |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.